AI joins the radiology team: 10,000-Patient trial tests smarter liver tumor detection
NCT ID NCT07153783
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 27 times
Summary
This completed study tested whether an artificial intelligence (AI) system can help doctors accurately identify liver tumors from contrast-enhanced CT scans. Over 10,000 adults participated, and the AI's main goal was to correctly tell malignant from non-malignant lesions. The approach combines AI analysis with human radiologist review to improve real-world diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110004, China
Conditions
Explore the condition pages connected to this study.